Carbometrics

Carbometrics

Specialist chemistry company with core competency of the design, synthesis and derivatisation of highly selective and robust carbohydrate-binding molecules.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
*

£2.1m

Seed
Total Funding000k
More about Carbometrics
Made with AI
Edit

Carbometrics is a pioneering company in the healthcare sector, focusing on the development of advanced glucose sensor technology. The company specializes in Biomimetic Glucose Binding Molecules (GBMs), which are designed to offer high selectivity towards glucose, even in complex biological mixtures. These GBMs are robust and have a multi-year operational potential, making them ideal for long-term use in Continuous Glucose Monitors (CGMs). Carbometrics operates in the medical device market, primarily serving clients in the diabetes care industry. The business model revolves around partnering with other companies to integrate their proprietary GBM technology into next-generation glucose sensors. Revenue is generated through these partnerships and licensing agreements. The company's mission is to improve the quality of life for people with diabetes by enabling more accurate and reliable glucose monitoring solutions.

Keywords: Biomimetic, Glucose, Binding Molecules, Diabetes, Continuous Glucose Monitors, Selectivity, Stability, Healthcare, Medical Devices, Partnerships.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo